【IHH 5225 交流专区】综合保健控股

icy97

Changes in Sub. S-hldr's Int. (29B)

IHH HEALTHCARE BERHAD

Particulars of substantial Securities Holder

Name	Pulau Memutik Ventures Sdn Bhd
Address	Level 33, Tower 2, Petronas Twin Towers, Kuala Lumpur City Centre, 50088 Kuala Lumpur.
NRIC/Passport No/Company No.	887202-X
Nationality/Country of incorporation	Malaysia
Descriptions (Class & nominal value)	Ordinary shares of RM1.00 each
Name & address of registered holder	Pulau Memutik Ventures Sdn Bhd Level 33, Tower 2, Petronas Twin Towers, Kuala Lumpur City Centre, 50088 Kuala Lumpur.

Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transaction	Date of change	No of securities	Price Transacted (RM)
Others	20/01/2014	75,000,000

Description of other type of transaction	Please refer to column "Circumstances by reason of which changed has occured"
Circumstances by reason of which change has occurred	Return of shares from Deutsche Bank AG, London Branch ("DB") made pursuant to the Securities Lending Agreement dated 18 October 2013 between Pulau Memutik Ventures Sdn Bhd and DB
Nature of interest	Direct
Direct (units)	3,580,570,634
Direct (%)	44.01
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Total no of securities after change	3,580,570,634
Date of notice	20/01/2014

foxycuttie

中国香港的禽流感会不会刺激这支股上升？

icy97

IHH HEALTHCARE BERHAD

Type	Announcement
Subject	OTHERS
Description	IHH HEALTHCARE BERHAD (“IHH” OR THE “COMPANY”) INTERNAL REORGANISATION OF THE IHH GROUP STRUCTURE
Pursuant to Paragraph 9.19(5) of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad and as part of the internal reorganisation of the IHH Group structure, the Board of Directors of IHH is pleased to announce that Acibadem Saglik Hizmetleri ve Ticaret A.S. (“Acibadem”), an indirect subsidiary of IHH, has on 30 January 2014 acquired 3,699,961 shares representing 82.22% of the equity interest in Acibadem Mobil Saglik Hizmetleri A.S. (“Acibadem Mobil”), an indirect subsidiary of Acibadem, from Acibadem Poliklinikleri A.S., a direct subsidiary of Acibadem, for a total consideration of TL3,699,961 (equivalent to RM5,457,812.50)1 (“Internal Reorganisation”). Subsequent thereto, Acibadem Mobil has become a direct wholly-owned subsidiary of Acibadem. The purchase consideration is determined based on the nominal value of the shares in Acibadem Mobil. The Internal Reorganisation will not have any effect on the issued and paid-up share capital and substantial shareholders’ shareholdings of IHH. There shall be no material effect on the Group’s earnings and net assets. None of the directors and major shareholders of IHH and persons connected to them has any interest,direct or indirect, in the Internal Reorganisation. _____________________________________ 1 Based on the exchange rate of TL1.00 : RM1.4751 on 30 January 2014, subject to rounding

icy97

亚股走低里拉贬值 综合保健创10个月低点

财经新闻 财经  2014-02-05 10:42
（吉隆坡4日讯）区域股市走跌和土耳其货币里拉贬值，拖累综合保健控股（IHH，5225，主板贸服股）股价创下逾10个月以来最低水平。

综合保健控股周二以3.63令吉开盘，即暴跌6.5%，触及全天最低3.45令吉。

午盘后收复失地，综合保健控股闭市报3.52令吉，全天滑落17仙或4.6%；成交量达到1167万7100股。

土耳其贡献营收40%

综合保健控股通过Acibadem控股，在土耳其经营15家医院，今天表现失色料是受到土耳其里拉波动的影响。

综合保健控股持有Acibadem控60%股权，集团营业额的40%贡献是来自于后者。

土耳其国内政治紧张局势升温，加上全球市场震荡，导致里拉汇率直线下坠。

土耳其央行1月28日紧急升息，遏制里拉屡创新低的跌势。

里拉兑换美元从去年10月迄今，下跌约12.4%。

相比同期内其他走跌的货币，里拉显著贬值，跌幅超越南非兰特和印尼盾的11.3%及9.3%。

MIDF投资研究点出，这些国家正面对双赤字问题，但不会蔓延至大马。【南洋网财经】

icy97

土耳其货币贬值 大马上市公司冲击微小

财经新闻 财经  2014-02-09 09:38
（吉隆坡8日讯）土耳其货币里拉近期的贬值，预期对在该国有业务的大马上市公司的业绩，不会带来明显冲击。

土耳其国内政治紧张局势升温，加上全球市场因美联储削减购债规模、外资在多个新兴市场撤离而震荡，导致里拉汇率直线下坠。

里拉兑换1美元的汇率，从去年11月的2.00，贬值至今年1月27日的2.339最低水平，跌幅高达16.9%。

但经过土耳其央行的升息扶持后，该汇率已有所回弹，截至2月7日闭市，里拉兑换1美元逐步回升至2.218的水平。

外国货币的贬值，无疑将对在当地有业务的大马公司，带来某种程度的冲击。

综合保健：狮城业务抵消

惟不愿具名的分析员告诉《南洋商报》，财报以令吉来计算的综合保健控股，整体上来看，外国货币波动并没有带来显著影响。

“虽然里拉兑令吉而言是贬值了，会导致来自土耳其业务的盈利贡献减少；但另一方面，令吉兑新元也是贬值了，所以，在新加坡拥有显著业务的盈利贡献会增加，这就产生了抵消作用。”

谈及综合保健控股在2月4日，曾一度大跌6.5%，被诠释为受里拉贬值影响的情况，该分析员认为，不能全然怪罪于里拉贬值，因为当日全球股市都倒地，该股只是顺势而跌。【南洋网财经】

perfectevo

IHH 10-12/13 的 REPORT 几时会出？

icy97

綜合保健末季業績料出色

2014-02-26 17:12      
（吉隆坡26日訊）綜合保健（IHH，5225，主板貿服組）即將公佈的業績料走高，分析員預計該公司3年盈利复合平均成長率達19%，主要是受擴充行動、營運效率提昇及醫藥旅遊業務等利好推動。

業績今出爐

大馬研究指出，綜合保健將在本月27日宣佈2013年財政年全年業績，預料第四季按季業績表現更佳，因第三季為傳統較疲弱季度。

該行預測2013年核心淨利為6億2千430萬，2014年為7億2千620萬，2015年為9億零70萬令吉。

大馬研究看好其強勁品牌及良好業務前景，惟估值達到2014財政年預測本益比37倍，顯得過於昂貴，比較區域同儕平均則僅為30倍。預料未來擴展行動落在大馬與土耳其。至於新加坡則沒有進一步擴張，僅限於提昇病床產能。

土耳其政治動盪，以及土耳其貨幣里拉匯率波動不靖，料是該公司股值進一步下調因素。

土耳其業務占該公司營收38%以及營運盈利的28%。土耳其擁有最高成長潛能，主要是它策略性地坐落在中東與北亞市場，以及有強勁的品牌支撐。

綜合保健償還了3億5千萬美元的土耳其債務之後，將降低其外匯波動的影響。土耳其上調利率對它沒有影響，因為它在土耳其的里拉債務是微不足道。

大馬研究關注該公司外匯轉換對盈利的衝擊。較為強勁的新元，將部份抵銷土耳其里拉匯率走貶損失。惟整體來看卻是利多於弊，因為新加坡業務作出較大盈利貢獻，占其營運盈利的43%，同時，土耳其業務以美元為單位的醫藥旅遊收入，將進一步彌補不足。

該行給予“持有”評級，合理價3令吉60仙，之前為3令吉90仙，主要反映旗下伊麗莎白諾威娜醫院的提昇行動較慢，調整外匯率假設，以及全面整合百匯生命REIT為子公司等因素。（星洲日報／財經‧報道：李文龍）

icy97

综合保健末季赚2.3亿

财经新闻 财经  2014-02-28 09:56
（吉隆坡27日讯）综合保健控股（IHH，5225，主板贸服股）末季净利按年扬升47%至2亿3010万令吉，相较上财年同期的1亿5650万令吉。

同期营业额扬16.5%报17亿8013万令吉，相较上财年同期的15亿2771万令吉。

该公司同时宣布派息2仙，并将在未来实行不少于净利20%的派息制度。

不过，汇率兑换损失与金融成本增加，导致综合保健控股全年营业额与净利下滑。

该公司全年净利按年跌16%至6亿3115万令吉；营业额则报67亿5645万令吉，按年跌幅近3%。【南洋网财经】

SUMMARY OF KEY FINANCIAL INFORMATION 31/12/2013

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/12/2013	31/12/2012	31/12/2013	31/12/2012
		$$'000	$$'000	$$'000	$$'000

1	Revenue	1,780,133	1,527,713	6,756,451	6,962,466
2	Profit/(loss) before tax	290,195	217,654	881,562	1,057,959
3	Profit/(loss) for the period	258,992	177,891	733,859	859,626
4	Profit/(loss) attributable to ordinary equity holders of the parent	230,100	156,508	631,159	750,798
5	Basic earnings/(loss) per share (Subunit)	2.83	1.94	7.78	10.76
6	Proposed/Declared dividend per share (Subunit)	0.02	0.00	0.02	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	2.2200		2.1300

Remarks :

The Board of Directors have recommended a first and final single tier cash dividend of 2 sen per ordinary share (2012: Nil) for the financial year ended 31 December 2013, subject to Shareholders’ approval at the forthcoming Annual General Meeting. The book closure and the payment date in respect of the proposed dividend will be determined by the Board of Directors at a later date.

Type	Announcement
Subject	OTHERS
Description	FIRST & FINAL SINGLE TIER CASH DIVIDEND FOR FINANCIAL YEAR ENDED 31 DECEMBER 2013
The Board of Directors is pleased to propose a first and final single tier cash dividend of 2 sen per ordinary share for the financial year ended 31 December 2013, subject to shareholders’ approval at the forthcoming Annual General Meeting. The book closure and the payment date in respect of the proposed dividend will be determined by the Board of Directors at a later date.

Type	Announcement
Subject	OTHERS
Description	DIVIDEND POLICY
The Board of Directors wishes to announce that the Company has adopted a dividend policy whereby not less than 20% of the Group's profit after tax and minority interests, excluding exceptional items, in respect of any financial year shall be distributed to its shareholders. In considering the level of dividend payments, the Board of Directors would take into account various factors including:- (i)    the level of the Group's available cash and cash equivalents; (ii)   return on equity and available retained earnings; and (iii)  the Group's projected levels of capital expenditure and other investment plans.

icy97

IHH HEALTHCARE BERHAD

Type	Announcement
Subject	OTHERS
Description	REVALUATION OF INVESTMENT PROPERTIES
Please refer to the attachment. http://www.bursamalaysia.com/market/listed-companies/company-announcements/1551269

Attachments IHH_Announcement_Revaluation_of_Investment_Properties_27022014.pdf

perfectevo

这个股票怎样？最近没什么动静

icy97

私人需求高支撑盈利 综合保健派息政策受看好

财经新闻 财经  2014-03-02 10:54
（吉隆坡1日讯）综合保健控股（IHH，5225，主板贸服股）终于公布股东引颈长盼多时的派息政策，倍受分析员看好，并放眼私人保健领域的高需求，可支撑集团盈利增长。

综合保健控股宣布2013财年业绩，也公布派发至少20%净利的股息政策。集团2013财年就派发每股2仙的股息，相等于26%派息率。

大众投行研究分析员表示，若集团接下来维持25%派息率，2014和2015财年的周息率料达到0.5%。

马银行投行分析员则点出，派息政策反映出公司资产负债表改善。

集团2013年末季的净负债对净有形资产提升，从0.4倍改善至0.35倍。集团去年营运现金流高达13亿令吉。

他认为，综合保健控股将可在不影响资产负债表的前提下，应付未来3年的34亿令吉资本开销计划。

基于高员工成本、营运开销和外汇亏损，综合保健控股2013财年净利按年下滑16%，营业额则滑落3%；整体表现符合分析员预测。

大马研究分析员表示，增加病床容量、提升营运效率和医疗旅游，将成为综合保健控股的盈利增长关键。

他指出，集团旗下主要市场的私人保健需求增长趋势，将可支撑集团的扩展计划。

他提到，大马和土耳其市场是医院扩展计划的主要增长动力，而新加坡Mount Elizabeth Novena医院将增加病床容量。

新马营运成本高

大部分分析员维持2014财年预测，唯有肯纳格投行及兴业研究分析员，分别降低综合保健控股现财年净利预测7%和2%。

除了2013财年表现欠缺亮点，他们下调预测，是考虑到集团在新加坡和大马的营运，可能面对高营运成本。

他们也调降集团的目标价，肯纳格投行给予3.86令吉，而兴业研究微调至3.85令吉。



【南洋网财经】

perfectevo

今天 3.85，最近还有机会上吗 ？

icy97

传综合保健164亿 竞标澳Health Scope

财经新闻 财经  2014-03-11 08:34
（吉隆坡10日讯）消息指出，综合保健控股（IHH，5225，主板贸服股）考虑竞标澳洲一家医院兼病理集团———HealthScope，交易价值可达50亿美元（约164亿1750万令吉）。

消息称HealthScope可能被被私募股权公司———TPG资本和Carlyle集团脱售。

《华尔街日报》引述消息人士指，把Healthscope脱售予买家只是其中一个可能。

TPG资本和Carlyle集团也可能考虑进行首次公开募股（IPO），或把Healthscope的产业和医院业务拆开脱售。

消息指，竞标预计在4月截止。

消息人士表示，综合保健控股仍未决定是否要竞标这项资产。

由国库控股（Khazanah）掌控的综合保健控股，正不断增长业务，期望能从东南亚或区域外上涨的医疗需求中受惠。

综合保健控股表示仍在寻求新投资，但却不愿透露就HealthScope给予回应。

公司发言人表示：“综合保健控股一直寻求各种可增值的机会，扩大旗下投资组合。不过，我们不方便针对某项交易给予回应。如果有任何重大的进展，我们会适时公布。”

Healthscope探讨上市

Healthscope是澳洲最大的医院和病理公司之一，旗下有33家医院、4家精神科医院和4项康复设施。

Healthscope也在纽西兰、大马、新加坡和越南经营病理业务。

另一方面，TPG资本和Carlyle集团也积极探讨让Healthscope上市。

消息称，两家公司已委任Macquarie、Credit Suisse和goldman Sachs进行一项deal。

医院集团管理层，正与亚洲、中东和美国的潜在基石投资者洽商，包括10亿美元（约32亿8350万令吉）债务、总值可达50亿美元（约164亿1750万令吉）的新上市计划。【南洋网财经】

icy97

綜合保健控股聯營 提供血液透析服務

企業財經19 Mar 2014 23:00
（吉隆坡19日訊）綜合保健控股（IHH，5225，主要板貿易）與新加坡Advanced Renal Care有限公司聯營，提供血液透析（Haemodialysis）服務。

該公司向馬證交所報備指出，兩家公司將聯合設立IMU Dialysis私人有限公司，綜合保健控股持60%股權，新加坡公司則持股40%。

文告指出，在該聯營計劃下，IMU Dialysis已于本月18日在1965年公司法令下成立，股本100萬股或100萬令吉。

“該公司將在國內設立、經營及理透析中心（dialysis centre），提供血液透析及相關服務。”

綜合保健控股在文告中指出，這項聯營計劃不會影響公司繳足資本及主要股東權益，並且不影響截至今年底財年收入及淨資產。【中国报财经】

Type	Announcement
Subject	OTHERS
Description	IHH HEALTHCARE BERHAD (“IHH” OR THE “COMPANY”) FORMATION OF 60%-OWNED JOINT VENTURE COMPANY BY IMU HEALTHCARE SDN BHD
Pursuant to Paragraph 9.19(23) of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of IHH is pleased to announce that IMU Healthcare Sdn Bhd (“IMU Healthcare”), an indirect wholly-owned subsidiary of IHH, had on 18 March 2014 formed a 60%-owned joint venture company (“Formation”), IMU Dialysis Sdn Bhd, pursuant to the Joint Venture Agreement dated 4 March 2014 entered into between IMU Healthcare and Advance Renal Care (Asia) Pte Ltd (“ARCA”). The remaining 40% equity stake in IMU Dialysis Sdn Bhd is owned by ARCA. Background information of IMU Dialysis Sdn Bhd IMU Dialysis Sdn Bhd was incorporated on 18 March 2014 in Malaysia under the Companies Act, 1965, as a private company limited by shares. The authorised share capital of IMU Dialysis Sdn Bhd is RM1,000,000.00 comprising 1,000,000 ordinary shares of RM1.00 each, of which 5 ordinary shares of RM1.00 each have been issued and fully paid-up. The principal activities of IMU Dialysis Sdn Bhd are establishing, operating and managing dialysis centre(s) for the provision of haemodialysis and its related services. Background information of ARCA ARCA was incorporated in Singapore as a private limited company under the Companies Act (Chapter 50) on 11 November 2011. The principal activity of ARCA is provision of haemodialysis treatment. Financial Effects The Formation will not have any effect on the issued and paid-up share capital and substantial shareholders’ shareholdings of IHH. There shall be no material effect on the Group’s earnings and net assets for the financial year ending 31 December 2014. Directors and Major Shareholders’ Interest None of the Directors and major shareholders of IHH and persons connected to them has any interest,direct or indirect, in the Formation.

icy97

綜合保健內部重組 子公司逾2.8億股權交易

財經股市31 Mar 2014 23:00
（吉隆坡31日訊）配合內部重組計劃，綜合保健控股（IHH，5225，主要板貿易）間接子公司百匯班底有限公司以9555萬新元（約2億8223萬令吉）收購百匯集團1950萬股。

綜合保健控股今日向馬證交所報備，是項收購計劃完成后，原本由百匯控股（Parkway Holdings）持有的子公司百匯集團，將會轉為百匯班底有限公司旗下。

為此百匯班底有限公司握有百匯集團70%股權，剩余30%由百匯控股所持有。

“這項內部重組計劃預計不會影響綜合保健控股截至今年12月底財年的繳足資本、收益、淨資產或負債。”

綜合保健控股指出，公司主要股東和董事並沒有從這項計劃中取得任何直接或間接利益。【中国报财经】

Type	Announcement
Subject	OTHERS
Description	INTERNAL REORGANISATION OF GROUP STRUCTURE
Pursuant to Paragraph 9.19(5) of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of IHH Healthcare Berhad (“IHH”) is pleased to announce that Parkway Pantai Limited (“PPL”), an indirect wholly-owned subsidiary of the Company has on 31 March 2014, subscribed for 19,500,000 ordinary shares of SGD4.90 each in Parkway Group Healthcare Pte Ltd ("PGH"), for a total consideration of SGD95,550,000 (equivalent to RM248,229,345*) (“Internal Reorganisation”). Prior to the Internal Reorganisation, PGH was a direct wholly-owned subsidiary of Parkway Holdings Ltd ('PHL") which in turn is a direct wholly-owned subsidiary of PPL. Upon completion of the Internal Reorganisation, PGH has become a 70% direct owned subsidiary of PPL while the remaining 30% is held by PHL. The Internal Reorganisation is not expected to have any effect on the issued and paid-up capital of IHH or IHH’s substantial shareholders’ shareholdings or any effect on the earnings, net assets or gearing of IHH on a consolidated basis for the financial year ending 31 December 2014. None of the directors or substantial shareholders of IHH or persons connected with them has any interest, whether direct or indirect in the Internal Reorganisation. * Based on the exchange rate of RM2.5979:SGD1.00 on 28 March 2014 as set out in the Bank Negara website, subject to rounding

icy97

傳Healthscope上市籌資‧綜合保健或打消購意

2014-04-04 16:58      
（吉隆坡4日訊）有鑑於情況生變，綜合保健（IHH,5225,主板貿服組）或決定中斷對澳洲醫院集團Healthscope公司高達50億澳元（約151億令吉）的收購計劃。

根據知情人士透露，基於Healthscope公司大股東--TPG資本和凱雷集團（Carlyle）改變初衷，計劃通過首次公開售股（IPO）籌集40億澳元的資金，致使綜合保健對Healthscope公司的興趣轉而變弱。

該名知情人士表示，Healthscope公司目前正與數家主權基金及其它買家進行商談，以認股擔任該集團的基石投資者。據悉，此次IPO最早將在今年7月展開。

TPG資本和凱雷集團發言人對此不予置評；綜合保健則表示，不會針對特定交易作出評論。

TPG資本和凱雷集團在3月期間探討脫售Healthscope公司的可能性，包括通過IPO或轉售等方式。然而，該名知情人士稱TPG資本和凱雷集團暫時還未敲定最後的方案。

Healthscope公司目前經營著44家醫院，為澳洲第2大私人醫院營運商。TPG資本和凱雷集團於2010年以27億澳元的價格將該集團收購至旗下。（星洲日報／財經）

icy97

IHH HEALTHCARE BERHAD

Type	Announcement
Subject	OTHERS
Description	Formation of a wholly-owned subsidiary in Turkey by Acıbadem Labmed Sağlık Hizmetleri A.Ş., an indirect subsidiary of IHH Healthcare Berhad ("IHH" or the "Company")
Pursuant to Paragraph 9.19(23) of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of IHH is pleased to announce that Acıbadem Labmed Sağlık Hizmetleri A.Ş.,an indirect subsidiary of the Company, had on 9 April 2014 formed a wholly-owned subsidiary in Turkey, details as follows :- Name of the Company Total issued and paid-up capital Equity interest Purchase consideration Principal activity Histogenetics Acıbadem Laboratuvar Hizmetleri A.Ş. TL50,000 100% TL50,000 (equivalent to RM76,780)* Provision of laboratory services The Formation will not have any effect on the issued and paid-up share capital and substantial shareholders’ shareholdings of IHH. There shall be no material effect on the Group’s earnings and net assets for the financial year ending 31 December 2014. None of the Directors and/or major shareholders or persons connected to them, have any interest, direct or indirect in the Formation. * Based on the exchange rate of TL1.00:RM1.5356 on 9 April 2014 as set out in Exchange Rates UK website, subject to rounding.

icy97

IHH HEALTHCARE BERHAD

Type	Announcement
Subject	OTHERS
Description	INTERNAL REORGANISATION OF GROUP STRUCTURE
Pursuant to Paragraph 9.19(5) of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of IHH Healthcare Berhad ("IHH" or "the Company") is pleased to announce that Pantai Premier Pathology Sdn Bhd, an indirect wholly-owned subsidiary of the Company has on 1 April 2014, acquired 2 ordinary shares of RM1.00 each, representing 100% of the total issued and paid-up share capital of Orifolio Options Sdn Bhd ("OOSB") from Mount Elizabeth Health Care Services Sdn Bhd, an indirect wholly-owned subsidiary of the Company, for a total cash consideration of RM2.00 ("Internal Reorganisation"). OOSB was incorporated on 4 July 1997 and its authorised and paid-up share capital are RM100,000.00 and RM2.00 respectively. The principal activity of OOSB is letting of property. The Internal Reorganisation will not have any effect on the issued and paid-up capital of IHH or IHH's substantial shareholders' shareholdings or any effect on the earnings, net assets or gearing of IHH on a consolidated basis. None of the directors or substantial shareholders of IHH or person connected with them has any interest whether direct or indirect in the Internal Reorganisation.

icy97

IHH HEALTHCARE BERHAD

EX-date	26/06/2014
Entitlement date	30/06/2014
Entitlement time	05:00:00 PM
Entitlement subject	First and Final Dividend
Entitlement description	A first and final single tier cash dividend of 2 sen per ordinary share of RM1.00 each for the financial year ended 31 December 2013
Period of interest payment	to
Financial Year End	31/12/2013
Share transfer book & register of members will be	to closed from (both dates inclusive) for the purpose of determining the entitlements
Registrar's name ,address, telephone no	Symphony Share Registrars Sdn Bhd Level 6, Symphony House Pusat Dagangan Dana 1 Jalan PJU 1A/46 47301 Petaling Jaya Selangor Darul Ehsan Tel No. : 03 7841 8000
Payment date	16/07/2014
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	30/06/2014
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Currency
Currency	Malaysian Ringgit (MYR)
Entitlement in Currency	0.02

icy97

美私募基金拟售151亿 传IHH竞标澳Healthscope

财经新闻 财经  2014-04-23 11:37
（吉隆坡22日讯）消息指出，综合保健控股（IHH，5225，主板贸服股）参与竞购澳洲医院兼病理集团———Healthscope。

根据《华尔街日报》报道，两家美国私募股权公司———TPG资本与Carlyle集团，有意以50亿澳元（约151亿令吉）脱售Healthscope。

除了综合保健控股，美国医院集团及中国上海复星医药集团，皆对Healthscope虎视眈眈。

消息人士称，首轮竞标活动将在5月初截止。

综合保健控股发言人表示，该公司一直积极寻求各种可增值的商机，借以扩大投资组合，但不方面评论任何交易。

“一旦有重大进展，我们会即时让市场知道。”

考虑多种脱售方式

追溯本月初的报道，综合保健控股因Healthscope考虑挂牌，而打消了收购念头。

TPG资本与Carlyle集团是在2010年，以27亿澳元（约82亿令吉）击败KRR&Co，购得Healthscope。

知情人士指出，这两家公司正进行“双重程序”，即与银行合作，把Healthscope卖给第三方，及首次公开募股（IPO），并考虑分拆和脱售产业资产。

对于上述传言，TPG资本与Carlyle集团皆不愿置评；而Healthscope发言人也无法即时作出回应。

Healthscope在澳洲拥有33间医院、4间心理健康医院及4间康复设施医院，在在纽西兰、大马、新加坡和越南亦有病理业务。【南洋网财经】